°Ë»ö°á°ú: ÃÑ 58°³ Áß 1 - 20 |
À̹«Å׶óÁ¤25mg(¾ÆÀÚƼ¿ÀÇÁ¸°)ÀÇ º´¿ë±Ý±â¿¡ ÇØ´çµÇ´Â Á¦Ç°
Á¦Ç°¸í¡ã | ¼ººÐ¸í | ÁÖ¼ººÐÄÚµå | Ç¥ÁØÄÚµå | ÆǸŻç | °í½Ã¹øÈ£ | Àû¿ëÀÏ |
°¡¿Àºê¸¯Á¤80mg(ÆäºÏ¼Ò½ºÅ¸Æ®)_(80mg/1Á¤) | febuxostat | 567401ATB | 649103040 | Çѱ¹ÈÞÅؽºÁ¦¾à(ÁÖ) | 20150021 | 20150423 |
±¸ÁÖÅäÆĽÃƼ´ÕÁ¤5¹Ð¸®±×·¥(ÅäÆĽÃƼ´Õ¾Æ½ºÆĸ£Æ®»ê¿°)_(7.131mg/1Á¤) | tofacitinib aspartate (as tofacitinib) | 693601ATB | 669805920 | ±¸ÁÖÁ¦¾à(ÁÖ) | 20240466 | 20241011 |
´ºÆÄƼ´ÕÁ¤5¹Ð¸®±×·¥(ÅäÆĽÃƼ´Õ¾Æ½ºÆĸ£Æ®»ê¿°)_(7.131mg/1Á¤) | tofacitinib aspartate (as tofacitinib) | 693601ATB | 678601820 | (ÁÖ)´Ù»êÁ¦¾à | 20240466 | 20241011 |
´ëÇÑÅäÆĽÃƼ´ÕÁ¤5¹Ð¸®±×·¥(ÅäÆĽÃƼ´Õ¾Æ½ºÆĸ£Æ®»ê¿°)_(7.131mg/1Á¤) | tofacitinib aspartate (as tofacitinib) | 693601ATB | 645104830 | ´ëÇѾàÇ°°ø¾÷(ÁÖ) | 20240466 | 20241011 |
¼¿ïÆäºÏ¼Ò½ºÅ¸Æ®Á¤40¹Ð¸®±×·¥_(40mg/1Á¤) | febuxostat | 567403ATB | 652904370 | (ÁÖ)¼¿ïÁ¦¾à | 20150021 | 20150423 |
¼¿ïÆäºÏ¼Ò½ºÅ¸Æ®Á¤80¹Ð¸®±×·¥_(80mg/1Á¤) | febuxostat | 567401ATB | 652904380 | (ÁÖ)¼¿ïÁ¦¾à | 20150021 | 20150423 |
¿ì¸®µéÅäÆĽÃƼ´ÕÁ¤5¹Ð¸®±×·¥(ÅäÆĽÃƼ´Õ¾Æ½ºÆĸ£Æ®»ê¿°)_(7.131mg/1Á¤) | tofacitinib aspartate (as tofacitinib) | 693601ATB | 670105110 | (ÁÖ)ÆÊÁ¨»çÀ̾𽺠| 20240466 | 20241011 |
À¯¸®°¡Æ®Á¤40¹Ð¸®±×·¥(ÆäºÏ¼Ò½ºÅ¸Æ®)_(40mg/1Á¤) | febuxostat | 567403ATB | 644502230 | (ÁÖ)À¯À¯Á¦¾à | 20150021 | 20150423 |
À¯¸®°¡Æ®Á¤80¹Ð¸®±×·¥(ÆäºÏ¼Ò½ºÅ¸Æ®)_(80mg/1Á¤) | febuxostat | 567401ATB | 644502220 | (ÁÖ)À¯À¯Á¦¾à | 20150021 | 20150423 |
À¯¼Ò¸¯Á¤40¹Ð¸®±×·¥(ÆäºÏ¼Ò½ºÅ¸Æ®)_(40mg/1Á¤) | febuxostat | 567403ATB | 645305220 | ÇѸ²Á¦¾à(ÁÖ) | 20150021 | 20150423 |
À¯¼Ò¸¯Á¤80¹Ð¸®±×·¥(ÆäºÏ¼Ò½ºÅ¸Æ®)_(80mg/1Á¤) | febuxostat | 567401ATB | 645305210 | ÇѸ²Á¦¾à(ÁÖ) | 20150021 | 20150423 |
ÀϼºÅäÆĽÃƼ´ÕÁ¤5¹Ð¸®±×·¥(ÅäÆĽÃƼ´Õ¾Æ½ºÆĸ£Æ®»ê¿°)_(7.131mg/1Á¤) | tofacitinib aspartate (as tofacitinib) | 693601ATB | 655404160 | Àϼº½Å¾à(ÁÖ) | 20240466 | 20241011 |
ÀèÆÄÁîÁ¤5¹Ð¸®±×·¥(ÅäÆĽÃƼ´Õ)_(5mg/1Á¤) | tofacitinib | 693701ATB | 645306420 | ÇѸ²Á¦¾à(ÁÖ) | 20240466 | 20241011 |
Á¦´Ï§Á¤5¹Ð¸®±×·¥(ÅäÆĽÃƼ´Õ¾Æ½ºÆĸ£Æ®»ê¿°)_(7.131mg/1Á¤) | tofacitinib aspartate (as tofacitinib) | 693601ATB | 649105160 | Çѱ¹ÈÞÅؽºÁ¦¾à(ÁÖ) | 20240466 | 20241011 |
Á©ÀÜÁî½Ã·´1mg/mL(ÅäÆĽÃƼ´Õ½ÃÆ®¸£»ê¿°)_(240mL/º´) | tofacitinib citrate(as tofacitinib) | 627205ASY | 648903841 | Çѱ¹ÈÀÌÀÚÁ¦¾à(ÁÖ) | 20240466 | 20241011 |
Á©ÀÜÁîÁ¤10¹Ð¸®±×·¥(ÅäÆĽÃƼ´Õ½ÃÆ®¸£»ê¿°)_(16.155mg/1Á¤) | tofacitinib citrate (as tofacitinib) | 627202ATB | 648903410 | Çѱ¹ÈÀÌÀÚÁ¦¾à(ÁÖ) | 20240466 | 20241011 |
Á©ÀÜÁîÁ¤5¹Ð¸®±×·¥(ÅäÆĽÃƼ´Õ½ÃÆ®¸£»ê¿°)_(8.078mg/1Á¤) | tofacitinib citrate (as tofacitinib) | 627201ATB | 648902810 | Çѱ¹ÈÀÌÀÚÁ¦¾à(ÁÖ) | 20240466 | 20241011 |
Á©ÀÜÁîXR¼¹æÁ¤11¹Ð¸®±×·¥(ÅäÆĽÃƼ´Õ½ÃÆ®¸£»ê¿°)_(17.771mg/1Á¤) | tofacitinib citrate (as tofacitinib) | 627204ATR | 648903570 | Çѱ¹ÈÀÌÀÚÁ¦¾à(ÁÖ) | 20240466 | 20241011 |
Á©ÆÄ´ÐÁ¤5¹Ð¸®±×·¥(ÅäÆĽÃƼ´Õ)_(5mg/1Á¤) | tofacitinib | 693701ATB | 644004520 | »ïÀÍÁ¦¾à(ÁÖ) | 20240466 | 20241011 |
Á©ÆÄƼ´ÕÁ¤5mg(ÅäÆĽÃƼ´Õ)_(5mg/1Á¤) | tofacitinib | 693701ATB | 658204520 | (ÁÖ)ºñº¸Á¸Á¦¾à | 20240466 | 20241011 |